About: Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.27 (-10.56%)
CNTX NASDAQ Context Therapeutics Inc
Context Therapeutics Inc share price
CNTX price activity
Last Price
$0.270
Change (24hr)
-0.03 USD (-10.56%)
Volume
1.03M
Volume (4w avg)
-
Open
$0.30
Day Range
$0.27 - $0.30
Previous Close
$0.31
Last Trade
13 Oct, 7:20 pm GMT+0
Delayed
13 Oct, 7:20 pm GMT+0
CNTX price performance
Delayed
13 Oct, 7:20 pm GMT+0
CNTX Market Signals